维普中文期刊产品整合服务
111篇 您的检索式:作者名="Andrea C F"
    题名 作者 年代 出处 被引量
1Capecitabine and irinotecan with and without bevacizumab for advanced colorectal cancer patients显示文摘AIM:To investigate the efficacy and safety of capecitabine plus irinotecan±bevacizumab in advanced or metastatic colorectal cancer patients. METHODS:Forty six patients with previously untreated,locally-advanced or metastatic colorectal cancer(mCRC) were recruited between 2001-2006 in a prospective open-label phaseⅡtrial,in German community-based outpatient clinics.Patients received a standard capecitabine plus irinotecan(CAPIRI) or CAPIRI plus bevacizumab(CAPIRI-BEV) regimen every 3 wk. Dose reductions were mandatory from the first cycle in cases of>grade 2 toxicity.The treatment choice of bevacizumab was at the discretion of the physician.Theprimary endpoints were response and toxicity and secondary endpoints included progression-free survival and overall survival. RESULTS:In the CAPIRI group vs the CAPRI-Bev group there were more female than male patients(47% vs 24%) ,and more patients had colon as the primary tumor site(58.8%vs 48.2%) with fewer patients having sigmoid colon as primary tumor site(5.9%vs 20.7%) .Grade 3/4 toxicity was higher with CAPIRI than CAPIRI-Bev:82%vs 58.6%.Partial response rates were 29.4%and 34.5%,and tumor control rates were 70.6%and 75.9%,respectively.No complete responses were observed.The median progression-free survival was 11.4 mo and 12.8 mo for CAPIRI and CAPIRI-Bev,respectively.The median overall survival for CAPIRI was 15 mo(458 d) and for CAPIRI-Bev 24 mo(733 d) .These differences were not statistically different.In the CAPIRI-Bev,group,two patients underwent a full secondary tumor resection after treatment,whereas in the CAPIRI group no cases underwent this procedure. CONCLUSION:Both regimens were well tolerated and offered effective tumor growth control in this outpatient setting.Severe gastrointestinal toxicities and thromboembolic events were rare and if observed were never fatal.Markus Moehler Martin F Sprinzl Murad Abdelfattah Carl C Schimanski Bernd Adami Werner Godderz Klaus Majer Dimitri Flieger Andreas Teufel Juergen Siebler Thomas Hoehler Peter R Galle Stephan Kanzler 2009World Journal of Gastroenterology2009,15,4:10
2Antimicrobial activity of a bovine hemoglobin fragment in the tick Boophilus rnicroplus 显示文摘Andrea C F Pedro I Teresa M 1999The Journal of Biological Chemistry1999,274,25:1
3Renal insufficiency following contrast media administration trial(REMEDIAL):arandomized comparison of 3 preventive strategies显示文摘Briguori c Airoldi F D'Andrea D 2007Circulation2007,115,10:1
4Determination of bonding in diamond-like carbon by Raman spectroscopy显示文摘Andrea C F 2002Diamond and related materials2002,11,:1
5Cerebral microbleeds andrecurrent stroke risk: systematic review and Meta-analysis ofprospective ischemic stroke and transient ischemic attackcohorts 显示文摘Andreas C Puneet K Zoe F 2013Stroke2013,44,4:1
6Infrarenal aortic and lower-extremity arterial disease: diagnostic performance of multidetector row CT angiography显示文摘Carlo C Francesco F Andrea L 2004Radiology2004,231,:1
7Major Proteins of Beer and Their Precursors in Barley : Electrophoretic and Immunolog- ical Studies 显示文摘Andrea C Giovanna P Luca F 1995Journal of Agricultural and Food Chemistry1995,43,10:1
8Renal insufficiency following contrast media administration trial (REMEDIAL):a randomized comparison of 3 preventive strategics显示文摘Briguori C Airoldi F D'Andrea D 2007Circulation2007,115,:1
9Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL):a randomized comparison of 3 preventive strategies显示文摘Briguori C Airoldi F D'Andrea D 0,,10:1
10Peripheral facial palsy secondary to middle-ear overpressure显示文摘Andrea C Meliet JL Staikowski F 2008Presse Med2008,37,42:1
11A Measure of Absorptive Capacity: Scale Development and Validation显示文摘Tessa C F Andreas E Shaker A Z 2011European Management Journal2011,29,2:1
12Renal insufficien ey following contrast media administration trial(REME DIAL):a randomized comparison of 3 preventive strate gies显示文摘Briguori C Airoldi F D' Andrea D 2007Circulation2007,115,10:1
13AHP-based evaluation of CMMS software 显示文摘Marcello B Gionata C Marco F Andrea G 2006Journal of Manufacturing Technology Management2006,17,5:1
14Swallowing disorders, pneumonia and respiratory tract infectious disease in the elderly 显示文摘Puisieux F D'Andrea C Baconnier P 2011Rev Mal Respir2011,28,8:1
15Psychiatric aspects of organ transplantation in critical care 显示文摘Andrea DM Catherine C Marian F 2008Critical Care Clinics2008,24,4:1
16A Visual GlobalPositioning System for Unmanned Aerial Vehicles Used in Photogrammetric Applications显示文摘Andrea C Emanuele F Adriano M 0,,01:1
17T-regulatory cells: key players in tumor immune escape and angiogenesis显示文摘Andrea F Motz GT George C 2012Cancer Res2012,72,23:1
18Experimental and analytical response of masonry elements under eccentric vertical loads显示文摘LIBORIO C ANDREA F LIDIA L M 2005Engineering Structures2005,27,8:1
19Infrarenal aortic and lower-extremity arterial disease:diagnostic performance of multi-detector row CT angiography显示文摘Carlo C Francesco F Andrea L 2004Radiology2004,231,2:1
20Microwave-assisted phase-transfer catalysis for the rapid one-pot methylation and gas chromatographic determination of phenolics显示文摘Yiannis C F Andreas K Constantine D S 2010Journal of the ChromatographA2010,1217,:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费